Metraipolis › archive › dc_d02f87a20f05

Recent Advances in AS101 and Tellurium-Based Nanoplatforms for Immunomodulation, Cancer Therapy, Antimicrobial Activity, and Toxicological Assessment — Europe PMC PMID:42540262

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42540262
DOI
10.1021/acsomega.6c03522
License (as archived)
solo-consultazione
Archived
2026-10-18T06:28:13.576Z
SHA-256 of the archived text
ad4ddb4d8817e327aa780494a2c0dabc453c29408dcf4f6309b00169936d8a72
Stable URL of this page
https://metraipolis.com/documento/dc_d02f87a20f05

How to cite

Recent Advances in AS101 and Tellurium-Based Nanoplatforms for Immunomodulation, Cancer Therapy, Antimicrobial Activity, and Toxicological Assessment — Europe PMC PMID:42540262 — Europe PMC (en), https://europepmc.org/article/MED/42540262 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d02f87a20f05 (Metraipolis archive dc_d02f87a20f05, sha256 ad4ddb4d8817e327aa780494a2c0dabc453c29408dcf4f6309b00169936d8a72)
BibTeX
@misc{dcd02f87a20f05,
  title = {Recent Advances in AS101 and Tellurium-Based Nanoplatforms for Immunomodulation, Cancer Therapy, Antimicrobial Activity, and Toxicological Assessment — Europe PMC PMID:42540262},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42540262},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d02f87a20f05; sha256 ad4ddb4d8817e327aa780494a2c0dabc453c29408dcf4f6309b00169936d8a72},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42540262. Agents can read the archived copy with the MCP tool read_document.